InChI=1S/C46H76NO10P/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 20- 21- 22- 24- 25- 27- 29- 31- 33- 35- 37- 44(48) 54- 39- 42(40- 55- 58(52,53) 56- 41- 43(47) 46(50) 51) 57- 45(49) 38- 36- 34- 32- 30- 28- 26- 23- 18- 16- 14- 12- 10- 8- 6- 4- 2/h5,7,11,13,17- 19,21- 23,25,27,31,33,42- 43H,3- 4,6,8- 10,12,14- 16,20,24,26,28- 30,32,34- 41,47H2,1- 2H3,(H,50,51) (H,52,53) /b7- 5- ,13- 11- ,19- 17- ,22- 21- ,23- 18- ,27- 25- ,33- 31- /t42- ,43+/m1/s1 |
RLZWFRUSWOIHNV-ZPDXEMAHSA-N |
[H] [C@] (COP(OC[C@@] (COC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC) =O) (OC(CCCCCCC/C=C\CCCCCCCC) =O) [H] ) (=O) O) (C(O) =O) N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via phosphatidyl-L-serine )
|
|
View more via ChEBI Ontology
(2S)- 2- amino- 3- ({[(2R)- 3- [(4Z,7Z,10Z,13Z,16Z,19Z)- docosa- 4,7,10,13,16,19- hexaenoyloxy]- 2- [(9Z)- octadec- 9- enoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid
|
HMDB
|
1-Docosahexaenoyl-2-oleoyl-sn-glycero-3-phosphoserine
|
HMDB
|
Phosphatidylserine(22:6/18:1)
|
HMDB
|
Phosphatidylserine(22:6n3/18:1n9)
|
HMDB
|
Phosphatidylserine(22:6w3/18:1w9)
|
HMDB
|
Phosphatidylserine(40:7)
|
HMDB
|
PS(22:6/18:1)
|
HMDB
|
PS(22:6n3/18:1n9)
|
HMDB
|
PS(22:6w3/18:1w9)
|
HMDB
|
PS(40:7)
|
HMDB
|
PSer(22:6/18:1)
|
HMDB
|
PSer(22:6n3/18:1n9)
|
HMDB
|
PSer(22:6w3/18:1w9)
|
HMDB
|
PSer(40:7)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|